These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 92787)

  • 1. [Autoimmune hepatitis (current state of research)].
    Juszczyk J
    Postepy Hig Med Dosw; 1979; 33(4):411-31. PubMed ID: 92787
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology of autoimmune liver diseases].
    Toda G; Zeniya M
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1403-8. PubMed ID: 8245635
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Ann Ital Med Int; 1996; 11(2):119-24. PubMed ID: 8974437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity in liver diseases.
    Doniach D
    Prog Clin Immunol; 1972; 1():45-70. PubMed ID: 4142094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunopathogenesis of chronic autoimmune hepatitis].
    García Buey L; García Monzón C; Moreno Otero R
    Rev Clin Esp; 1993 Sep; 193(4):197-205. PubMed ID: 8234987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiology and pathophysiology of autoimmune hepatitis].
    Toda G
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):209-15. PubMed ID: 7963941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic mechanisms of cell damage and pathogenetic correlations in acute and chronic hepatitis].
    Realdi G; Alberti A; Trevisan A; Bortolotti F; Tremolada F; Rigoli AM
    Minerva Med; 1978 Aug; 69(38):2555-67. PubMed ID: 309565
    [No Abstract]   [Full Text] [Related]  

  • 9. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
    Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
    Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the mononuclear cell infiltrate in piecemeal necrosis.
    Alexander G; Williams R
    Lab Invest; 1984 Mar; 50(3):247-9. PubMed ID: 6366361
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.
    Frazer IH; Mackay IR
    Clin Exp Immunol; 1984 Aug; 57(2):429-37. PubMed ID: 6432384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune hepatitis: evolving concepts.
    Diamantis I; Boumpas DT
    Autoimmun Rev; 2004 Mar; 3(3):207-14. PubMed ID: 15110233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients.
    Lohse AW; Gerken G; Mohr H; Löhr HF; Treichel U; Dienes HP; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1995 Sep; 33(9):527-33. PubMed ID: 8525656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases.
    Smith MG; Eddleston AL; Williams R
    Clin Gastroenterol; 1975 May; 4(2):297-313. PubMed ID: 1092487
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver membrane autoantibodies: methods for their detection and clinical significance.
    Nagai S; Manns M; Meyer zum Büschenfelde KH
    Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-specific protein: more questions than answers.
    Dienstag JL; Isselbacher KJ
    N Engl J Med; 1978 Jul; 299(1):40-2. PubMed ID: 78441
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis.
    Stechemesser E; Klein R; Berg PA
    Hepatology; 1993 Jul; 18(1):1-9. PubMed ID: 8325600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell mediated cytotoxicity to autologous hepatocytes in hepatitis B virus infection: facts, limits and relevance.
    Boltz-Nitulescu G; Penner E; Gangl A
    Z Gastroenterol; 1985 Apr; 23(4):188-91. PubMed ID: 2414933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.